NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes

Peter L. Greenberg, Cynthia K. Rigsby, Richard M. Stone, H. Joachim Deeg, Steven D. Gore, Michael M. Millenson, Stephen D. Nimer, Margaret R. O'Donnell, Paul J. Shami, Rashmi Kumar

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

The National Comprehensive Cancer Network (NCCN) convened a multidisciplinary task force to critically review the evidence for iron chelation and the rationale for treatment of transfusional iron overload in patients with myelodysplastic syndromes (MDS). The task force was charged with addressing issues related to tissue iron toxicity; the role of MRI in assessing iron overload; the rationale and role of treating transfusional iron overload in patients with MDS; and the impact of iron overload on bone marrow transplantation. This report summarizes the background data and ensuing discussion from the NCCN Task Force meeting on transfusional iron overload in MDS.

Original languageEnglish (US)
Pages (from-to)S1-16
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume7
DOIs
StatePublished - Dec 1 2009

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes'. Together they form a unique fingerprint.

  • Cite this

    Greenberg, P. L., Rigsby, C. K., Stone, R. M., Deeg, H. J., Gore, S. D., Millenson, M. M., Nimer, S. D., O'Donnell, M. R., Shami, P. J., & Kumar, R. (2009). NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes. Journal of the National Comprehensive Cancer Network : JNCCN, 7, S1-16. https://doi.org/10.6004/jnccn.2009.0082